Amgen raises 2026 guidance after Q3 beats
FROM THE WIRE · SEEKINGALPHA.COM
Amgen raises 2026 guidance after Q3 beats on the top and bottom lines. Read more here.
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishA full-year guidance raise from a large biotech can move the stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Amgen raised its 2026 guidance.
- 02The revision follows Q3 beats on both the top and bottom lines.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets